UCBCares is Dedicated to Providing Caring Experiences
UCBCares® is UCB, Inc.'s single source solution center in the U.S. dedicated to providing exceptional caring experiences and solutions for all incoming inquiries to UCB from patients, caregivers, and healthcare providers.
Press Release: CIMZIA® (certolizumab pegol) label update marks major advance for women of childbearing age with chronic inflammatory disease in the U.S.
CIMZIA® (certolizumab pegol) label update marks major advance for women of childbearing age with chronic inflammatory disease in the U.S.
UCB Sponsors New Exhibit at Atlanta’s Fernbank Museum
UCB is dedicated to supporting STEM education in the communities where we work and live. As part of this commitment, UCB is a proud sponsor of the new special exhibit, “The Secret World Inside You,” at Atlanta’s Fernbank Museum of Natural History.
Ben Morrison—comedian and Crohn’s Advocate—speaks candidly about his experience living with Crohn’s disease. He shares personal insights on the progress of Crohn’s care and the availability of information over the last 20 years.
Insurance Tips and Resources for Managing your Plan
It’s that time of the year again. Open enrollment for insurance has closed, and it is time to start using your new 2018 plans. Sometimes, understanding your health coverage and planning for your healthcare needs can be challenging.
Following a recent review of Tussionex® (hydrocodone polistirex and chlorpheniramine polistirex) – a cough syrup containing hydrocodone and chlorpheniramine– we determined the benefit-risk balance for the use of Tussionex® to treat cough associated with cold or allergy in children was no longer favorable. Because of this, UCB proactively approached the U.S. Food and Drug Administration (FDA) to request that Tussionex® be limited to use in adults.